These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1688831)

  • 1. Vaccination against polyoma virus (PyV) tumors using vaccinia-PyV recombinants: a major tumor-specific transplantation antigen (TSTA) epitope resides within the C-terminal segment of middle-T protein.
    Kieny MP; Gautier C; Tomasetto C; Kuhn I; Hareuveni M; Clertant P; Lathe R
    Int J Cancer; 1990 Jan; 45(1):185-9. PubMed ID: 1688831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant polyoma--vaccinia viruses: T antigen expression vectors and anti-tumor immunization agents.
    Clertant P; Kieny MP; Lecocq JP; Guizani I; Chambon P; Cuzin F; Lathe R
    Biochimie; 1988 Aug; 70(8):1075-87. PubMed ID: 2852508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polyomavirus tumor-specific transplantation antigen (TSTA) epitope is situated within the N-terminal amino acid sequence common to middle and small T-antigens.
    Reinholdsson G; Ramqvist T; Brandberg J; Dalianis T
    Virology; 1988 Oct; 166(2):616-9. PubMed ID: 2459846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against the polyoma tumor-specific transplantation antigen (TSTA) with polyoma T-antigens.
    Ramqvist T; Pallas DO; DeAnda J; Ahrlund-Richter L; Reinholdsson G; Roberts TM; Schaffhausen BS; Dalianis T
    Int J Cancer; 1988 Jul; 42(1):123-8. PubMed ID: 2839427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the polyoma virus tumor-specific transplantation antigen (TSTA).
    Dalianis T
    Adv Cancer Res; 1990; 55():57-85. PubMed ID: 1696775
    [No Abstract]   [Full Text] [Related]  

  • 6. A single peptide derived from the sequence common to polyoma small and middle T-antigen induces immunity against polyoma tumors.
    Ramqvist T; Reinholdsson G; Carlquist M; Bergman T; Dalianis T
    Virology; 1989 Sep; 172(1):359-62. PubMed ID: 2475972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour prevention and rejection with recombinant vaccinia.
    Lathe R; Kieny MP; Gerlinger P; Clertant P; Guizani I; Cuzin F; Chambon P
    Nature; 1987 Apr 30-May 6; 326(6116):878-80. PubMed ID: 3033512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of polyoma virus early proteins expressed from vaccinia virus recombinants.
    Guizani I; Kieny MP; Lathe R; Clertant P
    Gene; 1988 Dec; 73(1):163-73. PubMed ID: 2977356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
    Lukacher AE; Wilson CS
    J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.
    Wilson CS; Moser JM; Altman JD; Jensen PE; Lukacher AE
    J Immunol; 1999 Apr; 162(7):3933-41. PubMed ID: 10201912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity.
    Berke Z; Palmer S; Bergman T; Wester D; Svedmyr J; Linder S; Jornvall H; Dalianis T
    J Virol; 1996 May; 70(5):3093-7. PubMed ID: 8627788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.
    Meneguzzi G; Cerni C; Kieny MP; Lathe R
    Virology; 1991 Mar; 181(1):62-9. PubMed ID: 1847269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role?
    Dalianis T; Ramqvist T; Klein G
    Int J Cancer; 1984 Sep; 34(3):403-6. PubMed ID: 6090322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
    Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
    Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour development.
    Meneguzzi G; Kieny MP; Lecocq JP; Chambon P; Cuzin F; Lathe R
    Vaccine; 1990 Jun; 8(3):199-204. PubMed ID: 2163573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles.
    Szomolanyi-Tsuda E; Le QP; Garcea RL; Welsh RM
    J Virol; 1998 Aug; 72(8):6665-70. PubMed ID: 9658113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens.
    Reinholdsson-Ljunggren G; Ramqvist T; Ahrlund-Richter L; Dalianis T
    Int J Cancer; 1992 Jan; 50(1):142-6. PubMed ID: 1370225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyoma T-antigen-derived synthetic peptides induce polyoma-virus-specific macrophage migration inhibition.
    Reinholdsson G; Ramqvist T; Szigeti R; Dalianis T
    Int J Cancer; 1989 Jun; 43(6):1165-8. PubMed ID: 2543648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.